Page last updated: 2024-08-23

tridemorph and Leukemia, Lymphocytic, Chronic, B-Cell

tridemorph has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bomben, R; Canzonieri, V; Colombatti, A; Danussi, C; Degan, M; Gattei, V; Perris, R; Radillo, O; Spessotto, P; Wasserman, B; Zucchetto, A1

Other Studies

1 other study(ies) available for tridemorph and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.
    Matrix biology : journal of the International Society for Matrix Biology, 2007, Volume: 26, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Cell Adhesion Molecules; Cell Movement; Female; Fibronectins; Gene Expression; Humans; Immunoglobulin Heavy Chains; Immunoglobulin Variable Region; Immunohistochemistry; Integrin alpha3beta1; Kalinin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Mutation; Protein Isoforms; RNA, Messenger

2007